Access cutting-edge adhd treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access adhd specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adhd treatment provided free
The study team will determine the association between d,l-methylphenidate (MPH) therapeutic outcomes in ADHD patients and genetic variants of CES1 and reveal key associations between CES1 genotypes and the PK and PD of MPH.
Sponsor: Icahn School of Medicine at Mount Sinai
Check if you qualify for this adhd clinical trial in Cincinnati, OH
If you're searching for adhd treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.